These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5607731)
1. [The development of a necrotic form of erysipelas after subcutaneous administration of a drug]. Plakhotniuk VIa Klin Med (Mosk); 1967 Jul; 45(7):127. PubMed ID: 5607731 [No Abstract] [Full Text] [Related]
2. [Dermatoplasty in the treatment of necrotic mastitis and breast erysipelas]. Izmaĭlov GA; Mavziutov LKh Khirurgiia (Mosk); 1993 Apr; (4):25-9. PubMed ID: 8084165 [TBL] [Abstract][Full Text] [Related]
4. [Necrotic lesions caused by subcutaneous injections of gentamycin and sisomicin]. Duterque M; Hubert-Asso AM; Corrard A Ann Dermatol Venereol; 1985; 112(9):707-8. PubMed ID: 4091422 [No Abstract] [Full Text] [Related]
5. [Necrotizing erysipelas--connections with angiological diseases]. Schultz-Ehrenburg U; Weindorf N; Tourbier H Z Hautkr; 1982 Dec; 57(23):1733-44. PubMed ID: 7164532 [TBL] [Abstract][Full Text] [Related]
6. [Erysipelas after breast cancer treatment]. Ben Salah H; Siala W; Maaloul I; Bouzid F; Frikha M; Daoud J Tunis Med; 2002 Aug; 80(8):465-8. PubMed ID: 12703126 [TBL] [Abstract][Full Text] [Related]
7. [The erysipelas as complication of a lymph oedema after therapy of mastocarcinomas (author's transl)]. Keinert K; Schalldach U; Schumann E Strahlentherapie; 1981 Feb; 157(2):91-3. PubMed ID: 7222137 [TBL] [Abstract][Full Text] [Related]
8. Sodium selenite as prophylaxis against erysipelas in secondary lymphedema. Kasseroller R Anticancer Res; 1998; 18(3C):2227-30. PubMed ID: 9703790 [TBL] [Abstract][Full Text] [Related]
9. [Necrotic form of erysipelas of the lower extremities complicated by sepsis]. Povstianoĭ NE; Kul'baka VS; Fedorovskaia EA Khirurgiia (Mosk); 1984 Jan; (1):142-3. PubMed ID: 6700159 [No Abstract] [Full Text] [Related]
10. Recurrent erysipelas caused by group B streptococcus organisms. Binnick AN; Klein RB; Baughman RD Arch Dermatol; 1980 Jul; 116(7):798-9. PubMed ID: 6772113 [TBL] [Abstract][Full Text] [Related]
11. Erysipelas of the upper extremity following locoregional therapy for breast cancer. El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307 [TBL] [Abstract][Full Text] [Related]
13. Erysipelas after breast cancer treatment (26 cases). Masmoudi A; Maaloul I; Turki H; Elloumi Y; Marrekchi S; Bouassida S; Ben Jemaa M; Zahaf A Dermatol Online J; 2005 Dec; 11(3):12. PubMed ID: 16409908 [TBL] [Abstract][Full Text] [Related]
14. [Erysipelas lymphogranulomatosum (lymphogranulomatosis erysipeloides of the skin)]. Undeutsch W; Fischer H; Hensel U Hautarzt; 1969 Jan; 20(1):314-9. PubMed ID: 5359056 [No Abstract] [Full Text] [Related]
15. [Harmless foot fungus? Not true! Threat of erysipelas]. Warpakowski A MMW Fortschr Med; 2005 Feb; 147(5):15. PubMed ID: 15766019 [No Abstract] [Full Text] [Related]
16. Erysipelas after venectomy for coronary artery bypass surgery. Dan M; Shapira I; Yakirewitch V; Vidne B; Shibolet S Isr J Med Sci; 1983 Dec; 19(12):1100-1. PubMed ID: 6607240 [No Abstract] [Full Text] [Related]
17. [Mitigated erysipelas after implantation of foreign material]. Sauer J; Weyer T; Seifert A Zentralbl Chir; 2004 Jun; 129(3):220-4. PubMed ID: 15237331 [TBL] [Abstract][Full Text] [Related]
18. [Allergic heparin-induced infiltrates and skin necrosis caused by subcutaneous injections of heparin]. Nodel'son SE; Chekhova EI; Fastovskiĭ VL Ter Arkh; 1984; 56(6):118-21. PubMed ID: 6236573 [TBL] [Abstract][Full Text] [Related]
19. [Predisposing and triggering factors in erysipelas]. Santos I; Andrade Lima MB; Andrade Lima BP Med Cutan Ibero Lat Am; 1984; 12(5):399-402. PubMed ID: 6396465 [TBL] [Abstract][Full Text] [Related]
20. [A case of a phlegmonous and necrotic form of erysipelas]. Fedotov VV; Shorokhova NI Sov Med; 1986; (9):121-2. PubMed ID: 3798211 [No Abstract] [Full Text] [Related] [Next] [New Search]